2-Ethynyl-4-fluoropyridine, 95%, 250mg

4-Formyl-3-(methylsulfonyl)benzonitrile, 98%, 1g

3-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95.0%, 5g

4-Chloro-6-methyl-2-(trifluoromethyl)quinoline, 97.0%, 250mg

2-(4-N-FMOC-MORPHOLIN-2-YL)ACETIC ACID, 95.0%, 500mg

4-amino-N-(1-isopropyl-1H-pyrazol-5-yl)butanamide dihydrochloride, 95.0%, 250mg

Benzamide, N-[4-[(2-amino-6-methyl-4-pyrimidinyl)amino]phenyl]-4-(4-quinolinylamino)-, 98%, 10mg

N-BOC-3-BROMO-6-CHLOROINDOLE, 97.0%, 5g

2-(4-Methoxy-2-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 5g

Recipiente de cristalización DURAN® sin pico, 40 ml, 50 mm, 10 Unidad(es)

(3,4-Dimethylphenyl)(pyridin-4-yl)methanone, 95%, 100mg

2-(Trifluoromethyl)phenethyl alcohol, 95.0%, 25g

Tert-butyl 4-amino-3-methoxybenzoate, 95+%, 100mg